BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24056857)

  • 1. Identification of hepatocellular carcinoma related genes with k-th shortest paths in a protein-protein interaction network.
    Jiang M; Chen Y; Zhang Y; Chen L; Zhang N; Huang T; Cai YD; Kong X
    Mol Biosyst; 2013 Nov; 9(11):2720-8. PubMed ID: 24056857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
    Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
    World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
    Li L; Lei Q; Zhang S; Kong L; Qin B
    Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying significant pathways of hepatitis B virus-related hepatocellular carcinoma based on crosstalk and network pathways.
    Wen LM; Wu WZ; Peng XC
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27420970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
    Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
    Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.
    Ueda T; Honda M; Horimoto K; Aburatani S; Saito S; Yamashita T; Sakai Y; Nakamura M; Takatori H; Sunagozaka H; Kaneko S
    Genomics; 2013 Apr; 101(4):238-48. PubMed ID: 23485556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the key genes and pathways in hepatocellular carcinoma development from hepatitis B virus‑positive cirrhosis.
    Chen QF; Xia JG; Li W; Shen LJ; Huang T; Wu P
    Mol Med Rep; 2018 Dec; 18(6):4940-4950. PubMed ID: 30272310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics analysis of gene expression alterations in microRNA‑122 knockout mice with hepatocellular carcinoma.
    He B; He Y; Shi W; Gong S; Chen X; Xiao J; Gu J; Ding W; Wang Y
    Mol Med Rep; 2017 Jun; 15(6):3681-3689. PubMed ID: 28393247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects.
    Kao JH; Chen PJ; Chen DS
    Adv Cancer Res; 2010; 108():21-72. PubMed ID: 21034965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening and function analysis of hub genes and pathways in hepatocellular carcinoma via bioinformatics approaches.
    Zhang L; Huang Y; Ling J; Zhuo W; Yu Z; Shao M; Luo Y; Zhu Y
    Cancer Biomark; 2018; 22(3):511-521. PubMed ID: 29843214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma.
    Kim DG
    Methods Mol Biol; 2006; 317():141-55. PubMed ID: 16264227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin (BIRC5) cell cycle computational network in human no-tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation.
    Wang L; Huang J; Jiang M; Sun L
    J Cell Biochem; 2011 May; 112(5):1286-94. PubMed ID: 21312234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Hepatitis C Virus in the dynamic protein interaction networks of hepatocellular cirrhosis and carcinoma.
    Huang T; Liu L; Liu Q; Ding G; Tan Y; Tu Z; Li Y; Dai H; Xie L
    Int J Comput Biol Drug Des; 2011; 4(1):5-18. PubMed ID: 21330691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
    Kurokawa Y; Honma K; Takemasa I; Nakamori S; Kita-Matsuo H; Motoori M; Nagano H; Dono K; Ochiya T; Monden M; Kato K
    Int J Oncol; 2006 Feb; 28(2):383-91. PubMed ID: 16391793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic significance and potential function of miR-338-5p in hepatocellular carcinoma: A bioinformatics study with microarray and RNA sequencing data.
    Liang L; Gao L; Zou XP; Huang ML; Chen G; Li JJ; Cai XY
    Mol Med Rep; 2018 Feb; 17(2):2297-2312. PubMed ID: 29207053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of hepatocellular carcinoma-related genes with a machine learning and network analysis.
    Gui T; Dong X; Li R; Li Y; Wang Z
    J Comput Biol; 2015 Jan; 22(1):63-71. PubMed ID: 25247452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
    Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
    Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dimensional biology to comprehend hepatocellular carcinoma.
    Vivekanandan P; Singh OV
    Expert Rev Proteomics; 2008 Feb; 5(1):45-60. PubMed ID: 18282123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative and integrative functional genomics of HCC.
    Lee JS; Thorgeirsson SS
    Oncogene; 2006 Jun; 25(27):3801-9. PubMed ID: 16799621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
    Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.